Matthew Francis Pine
Known title: DirectorCIK: 0001807057
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Xylem sees broad analyst price target cuts. Several major banks, including Mizuho, Oppenheimer, and Citigroup, recently lowered their price targets for Xylem. While most firms maintained positive ratings, the reduction in targets reflects a more conservative outlook on the stock's near-term value. The company also announced it will participate in upcoming investor conferences to discuss its strategy.
Transaction History
| TT | ▼ Sell | Tax Withholding | 112 | $51K | 6/5/2026 | View on chart |
| TT | ▲ Buy | Grant | 438 | $0 | 6/5/2026 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 1,846 | $233K | 3/5/2026 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 847 | $109K | 3/2/2026 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 2,316 | $299K | 3/2/2026 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 4,927 | $635K | 3/2/2026 | View on chart |
| XYL | ▲ Buy | Grant | 16,105 | $0 | 3/2/2026 | View on chart |
| XYL | ▲ Buy | Grant | 5,243 | $676K | 3/1/2026 | View on chart |
| XYL | ▲ Buy | Grant | 2,943 | $380K | 3/1/2026 | View on chart |
| XYL | ▲ Buy | Grant | 2,152 | $278K | 3/1/2026 | View on chart |
| XYL | ▲ Buy | Grant | 4,328 | $558K | 3/1/2026 | View on chart |
| TT | ▲ Buy | Grant | 465 | $0 | 6/5/2025 | View on chart |
| XYL | ▼ Sell | Gift | 34,007 | $4.2M | 3/11/2025 | View on chart |
| XYL | ▲ Buy | Grant | 14,074 | $1.8M | 3/5/2025 | View on chart |
| XYL | ▲ Buy | Grant | 2,524 | $328K | 3/1/2025 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 3,084 | $400K | 3/1/2025 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 2,134 | $277K | 3/1/2025 | View on chart |
| XYL | ▲ Buy | Grant | 3,026 | $393K | 3/1/2025 | View on chart |
| XYL | ▲ Buy | Grant | 3,026 | $393K | 3/1/2025 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 1,456 | $186K | 3/1/2024 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 2,281 | $292K | 3/1/2024 | View on chart |
| XYL | ▲ Buy | Grant | 2,206 | $282K | 3/1/2024 | View on chart |
| XYL | ▲ Buy | Grant | 3,586 | $459K | 3/1/2024 | View on chart |
| XYL | ▲ Buy | Grant | 12,701 | $1.6M | 3/1/2024 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 6,316 | $688K | 5/7/2023 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 794 | $80K | 3/1/2023 | View on chart |
| XYL | ▲ Buy | Grant | 4,946 | $0 | 3/1/2023 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 1,747 | $179K | 2/27/2023 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 359 | $37K | 2/27/2023 | View on chart |
| XYL | ▲ Buy | Grant | 7,053 | $0 | 2/27/2023 | View on chart |
| XYL | ▼ Sell | Open Market | 900 | $98K | 11/4/2022 | View on chart |
| XYL | ▼ Sell | Open Market | 7,588 | $809K | 11/4/2022 | View on chart |
| XYL | ▼ Sell | Open Market | 3,382 | $364K | 11/4/2022 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 5,511 | $468K | 5/9/2022 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 217 | $19K | 3/1/2022 | View on chart |
| XYL | ▲ Buy | Grant | 3,458 | $0 | 3/1/2022 | View on chart |
| XYL | ▼ Sell | Tax Withholding | 350 | $31K | 2/27/2022 | View on chart |
| XYL | ▲ Buy | Option Exercise | 1,000 | $64K | 1/3/2022 | View on chart |
| XYL | ▼ Sell | Open Market | 1,000 | $120K | 1/3/2022 | View on chart |
| XYL | ▲ Buy | Option Exercise | 2,000 | $127K | 12/1/2021 | View on chart |
| XYL | ▼ Sell | Open Market | 2,000 | $243K | 12/1/2021 | View on chart |
| XYL | ▲ Buy | Option Exercise | 2,000 | $127K | 11/5/2021 | View on chart |
| XYL | ▼ Sell | Open Market | 2,000 | $261K | 11/5/2021 | View on chart |
| XYL | ▲ Buy | Option Exercise | 2,000 | $127K | 10/1/2021 | View on chart |
| XYL | ▼ Sell | Open Market | 2,000 | $243K | 10/1/2021 | View on chart |
| XYL | ▲ Buy | Option Exercise | 2,000 | $127K | 9/1/2021 | View on chart |
| XYL | ▼ Sell | Open Market | 2,000 | $273K | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Goldman Sachs Upgrades Trane Technologies to Buy, Raises Target
Goldman Sachs upgraded Trane Technologies to Buy and raised its price target to $565. This follows a Neutral rating from Mizuho, which set a lower target of $485. The stock is currently trading near its support level, with analysts generally viewing the company's valuation as fair given its focus on heat pumps and building efficiency.
Goldman Sachs Upgrades Trane Technologies to Buy, Raises Target. Goldman Sachs upgraded Trane Technologies to Buy and raised its price target to $565. This follows a Neutral rating from Mizuho, which set a lower target of $485. The stock is currently trading near its support level, with analysts generally viewing the company's valuation as fair given its focus on heat pumps and building efficiency.